Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke
Standard
Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. / Saver, Jeffrey L; Goyal, Mayank; Bonafe, Alain; Diener, Hans-Christoph; Levy, Elad I; Pereira, Vitor M; Albers, Gregory W; Cognard, Christophe; Cohen, David J; Hacke, Werner; Jansen, Olav; Jovin, Tudor G; Mattle, Heinrich P; Nogueira, Raul G; Siddiqui, Adnan H; Yavagal, Dileep R; Baxter, Blaise W; Devlin, Thomas G; Lopes, Demetrius K; Reddy, Vivek K; du Mesnil de Rochemont, Richard; Singer, Oliver C; Jahan, Reza; SWIFT PRIME Investigators.
In: NEW ENGL J MED, Vol. 372, No. 24, 11.06.2015, p. 2285-95.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke
AU - Saver, Jeffrey L
AU - Goyal, Mayank
AU - Bonafe, Alain
AU - Diener, Hans-Christoph
AU - Levy, Elad I
AU - Pereira, Vitor M
AU - Albers, Gregory W
AU - Cognard, Christophe
AU - Cohen, David J
AU - Hacke, Werner
AU - Jansen, Olav
AU - Jovin, Tudor G
AU - Mattle, Heinrich P
AU - Nogueira, Raul G
AU - Siddiqui, Adnan H
AU - Yavagal, Dileep R
AU - Baxter, Blaise W
AU - Devlin, Thomas G
AU - Lopes, Demetrius K
AU - Reddy, Vivek K
AU - du Mesnil de Rochemont, Richard
AU - Singer, Oliver C
AU - Jahan, Reza
AU - SWIFT PRIME Investigators
AU - Thomalla, Götz
PY - 2015/6/11
Y1 - 2015/6/11
N2 - BACKGROUND: Among patients with acute ischemic stroke due to occlusions in the proximal anterior intracranial circulation, less than 40% regain functional independence when treated with intravenous tissue plasminogen activator (t-PA) alone. Thrombectomy with the use of a stent retriever, in addition to intravenous t-PA, increases reperfusion rates and may improve long-term functional outcome.METHODS: We randomly assigned eligible patients with stroke who were receiving or had received intravenous t-PA to continue with t-PA alone (control group) or to undergo endovascular thrombectomy with the use of a stent retriever within 6 hours after symptom onset (intervention group). Patients had confirmed occlusions in the proximal anterior intracranial circulation and an absence of large ischemic-core lesions. The primary outcome was the severity of global disability at 90 days, as assessed by means of the modified Rankin scale (with scores ranging from 0 [no symptoms] to 6 [death]).RESULTS: The study was stopped early because of efficacy. At 39 centers, 196 patients underwent randomization (98 patients in each group). In the intervention group, the median time from qualifying imaging to groin puncture was 57 minutes, and the rate of substantial reperfusion at the end of the procedure was 88%. Thrombectomy with the stent retriever plus intravenous t-PA reduced disability at 90 days over the entire range of scores on the modified Rankin scale (P<0.001). The rate of functional independence (modified Rankin scale score, 0 to 2) was higher in the intervention group than in the control group (60% vs. 35%, P<0.001). There were no significant between-group differences in 90-day mortality (9% vs. 12%, P=0.50) or symptomatic intracranial hemorrhage (0% vs. 3%, P=0.12).CONCLUSIONS: In patients receiving intravenous t-PA for acute ischemic stroke due to occlusions in the proximal anterior intracranial circulation, thrombectomy with a stent retriever within 6 hours after onset improved functional outcomes at 90 days. (Funded by Covidien; SWIFT PRIME ClinicalTrials.gov number, NCT01657461.).
AB - BACKGROUND: Among patients with acute ischemic stroke due to occlusions in the proximal anterior intracranial circulation, less than 40% regain functional independence when treated with intravenous tissue plasminogen activator (t-PA) alone. Thrombectomy with the use of a stent retriever, in addition to intravenous t-PA, increases reperfusion rates and may improve long-term functional outcome.METHODS: We randomly assigned eligible patients with stroke who were receiving or had received intravenous t-PA to continue with t-PA alone (control group) or to undergo endovascular thrombectomy with the use of a stent retriever within 6 hours after symptom onset (intervention group). Patients had confirmed occlusions in the proximal anterior intracranial circulation and an absence of large ischemic-core lesions. The primary outcome was the severity of global disability at 90 days, as assessed by means of the modified Rankin scale (with scores ranging from 0 [no symptoms] to 6 [death]).RESULTS: The study was stopped early because of efficacy. At 39 centers, 196 patients underwent randomization (98 patients in each group). In the intervention group, the median time from qualifying imaging to groin puncture was 57 minutes, and the rate of substantial reperfusion at the end of the procedure was 88%. Thrombectomy with the stent retriever plus intravenous t-PA reduced disability at 90 days over the entire range of scores on the modified Rankin scale (P<0.001). The rate of functional independence (modified Rankin scale score, 0 to 2) was higher in the intervention group than in the control group (60% vs. 35%, P<0.001). There were no significant between-group differences in 90-day mortality (9% vs. 12%, P=0.50) or symptomatic intracranial hemorrhage (0% vs. 3%, P=0.12).CONCLUSIONS: In patients receiving intravenous t-PA for acute ischemic stroke due to occlusions in the proximal anterior intracranial circulation, thrombectomy with a stent retriever within 6 hours after onset improved functional outcomes at 90 days. (Funded by Covidien; SWIFT PRIME ClinicalTrials.gov number, NCT01657461.).
KW - Acute Disease
KW - Administration, Intravenous
KW - Aged
KW - Brain Ischemia
KW - Combined Modality Therapy
KW - Endovascular Procedures
KW - Female
KW - Fibrinolytic Agents
KW - Humans
KW - Male
KW - Middle Aged
KW - Stents
KW - Stroke
KW - Thrombectomy
KW - Tissue Plasminogen Activator
KW - Treatment Outcome
U2 - 10.1056/NEJMoa1415061
DO - 10.1056/NEJMoa1415061
M3 - SCORING: Journal article
C2 - 25882376
VL - 372
SP - 2285
EP - 2295
JO - NEW ENGL J MED
JF - NEW ENGL J MED
SN - 0028-4793
IS - 24
ER -